Elite Pharmaceuticals, Inc. Gain (Loss) on Disposition of Assets
Elite Pharmaceuticals, Inc. (ELTP) reported Gain (Loss) on Disposition of Assets of $48.46 thousand for the 12-month period ending 2021-03-31, per its 10-K filed 2022-06-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2022-06-29
- Elite Pharmaceuticals, Inc. gain (loss) on disposition of assets for the quarter ending 2021-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. gain (loss) on disposition of assets for the quarter ending 2020-12-31 was $6.97K.
- Elite Pharmaceuticals, Inc. gain (loss) on disposition of assets for fiscal 2021 was $48.46K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-29 | $6.97K derived: sum of 2 quarters · filed 2022-06-29 | $48.46K 10-K · filed 2022-06-29 | |
| 2020-12-31 | $6.97K 10-Q · filed 2022-02-14 | $48.46K 10-Q · filed 2022-02-14 |